Healthcare
Gilead Sciences, Inc.
GILD$151.00-0.15%
Price is delayed.
Add to watchlist
About Gilead Sciences, Inc.
Gilead Sciences makes antiviral drugs, including treatments for HIV and hepatitis C. Their HIV medications are used by millions of patients worldwide. The company also developed remdesivir, which was used to treat COVID-19. They generate strong cash flow and pay a growing dividend.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore